TGA / PMDA / NMPA · Asia-Pacific
zinc — TGA / PMDA / NMPA regulatory status
zinc (NULL) regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: TGA approved.
Status snapshot
- Status
- TGA approved
- Brand
- NULL
- Mechanism
- Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.
- Structured fields
- 6
Pharmacology context used for competitive intelligence: Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.. This page is a status aggregation for professional reference — not prescribing advice.
Regional decision snapshot — TGA: approved.
Linked evidence on this spoke: 7 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| TGA | Australia | approved | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| Zinc sulphate | Phase 3 | United Therapeutics Europe | NCT01166815 |
| Zinc sulphate 20 mg | Phase 3 | United Therapeutics Europe | NCT00355043 |
| zinc sulphate dietary supplement | Phase 3 | United Therapeutics Europe | NCT00109551 |
| zinc supplementation | Phase 2 | United Therapeutics Europe | NCT00138047 |
| iron and zinc combined | Approved | United Therapeutics Europe | NCT00470158 |
| Zinc gluconate | Unknown | Grace Therapeutics | NCT02856269 |
| zinc | Unknown | BRIGHT MINDS BIOSCIENCES | NCT00149552 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12077551 | Zinc complex, preparation thereof and use thereof for trerapy of human and animal diseases | US |
| 11713305 | Zinc sensors for in vivo imaging of beta-cell function by MRI | US |
| 11421007 | Zinc finger protein compositions for modulation of huntingtin (Htt) | US |
| 11267832 | Mn(II)-based sensors to detect zinc in vivo with MRI | US |
| 11125741 | Compositions and methods for the detection of zinc | US |
| 9897595 | Compositions and methods for the detection of zinc | US |
| 9757209 | Compositions and methods for dental applications involving zinc-oxide cements | US |
| 9717759 | Modification of CXCR4 using engineered zinc finger proteins | US |
| 9624498 | Methods and compositions for regulation of zinc finger protein expression | US |
| 9284251 | Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions | US |
| 9234016 | Engineered zinc finger proteins for treating trinucleotide repeat disorders | US |
| 9163245 | Compositions for linking zinc finger modules | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of zinc?
zinc currently shows TGA approved in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get zinc regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to zinc?
This spoke lists 7 published programs associated with zinc in our pipeline index.